Risk Intelligence
Volatility in ammonia and sulfur prices
View Risks →Coromandel reported a strong Q2 FY26 with consolidated revenue of ₹9,771 crore (+30% YoY) and PAT of ₹793 crore (+20% YoY), driven by robust fertilizer volumes (NPK production up 3% to 9.1 lakh tons) and a sharp recovery in crop protection (EBIT +48% to ₹16...
Financial stats pending filing verification
Coromandel reported a strong Q2 FY26 with consolidated revenue of ₹9,771 crore (+30% YoY) and PAT of ₹793 crore (+20% YoY), driven by robust fertilizer volumes (NPK production up 3% to 9.1 lakh tons) and a sharp recovery in crop protection (EBIT +48% to ₹162 crore). The company gained market share in phosphatic fertilizers to 19% (vs 17% last year) and is on track to commission its Kakinada phosphoric/sulfuric acid plant by January, which is expected to deliver a 2-year payback on ₹1,000 crore investment. Management guided for 25% growth in domestic formulation business and reiterated a minimum ₹5,500/ton EBITDA target for fertilizers. Key risks include volatility in ammonia/sulfur prices and delayed defense drone order execution at DUXA.
कोरोमंडल ने दूसरी तिमाही में शानदार प्रदर्शन किया। कंपनी की कुल कमाई ₹9,771 करोड़ रही, जो पिछले साल से 30% ज्यादा है। मुनाफा ₹793 करोड़ हुआ, जो 20% बढ़ा। इसकी वजह खाद की बिक्री में तेजी और फसल सुरक्षा कारोबार में सुधार है। फॉस्फेटिक खाद में बाजार हिस्सेदारी 17% से बढ़कर 19% हो गई। कंपनी जनवरी तक काकीनाडा में नया प्लांट शुरू करेगी, जिसमें ₹1,000 करोड़ का निवेश दो साल में वसूल हो जाएगा। प्रबंधन ने घरेलू दवा कारोबार में 25% बढ़ोतरी का अनुमान लगाया है। खतरे में अमोनिया और सल्फर की कीमतों में उतार-चढ़ाव और ड्रोन ऑर्डर में देरी शामिल है।
Volatility in ammonia and sulfur prices
View Risks →Full transcript text is available on this route.
Read Transcript →Plants operated above capacity despite ammonia supply disruption in September.
Coromandel became the largest marketer of phosphatic fertilizers in India.
Driven by strong export demand for mancozeb and improved domestic formulation margins.
Doubled volumes; farmer adoption improving, especially in fruits and vegetables.
Mechanical completion expected in December 2025, trial runs in January, commercial production by mid-January.
Spike in ammonia and sulfur during Q2 impacted production; management expects softening but uncertainty remains.
View Risks →